Systematic review of antibiotic prescription associated with upper respiratory tract infections in China

Medicine (United States)

Volumn 95, Issue 19, 2016, Pages

  Li, Jing ^a   Song, Xingyue ^a   Yang, Tingting ^a   Chen, Yawen ^a   Gong, Yanhong ^a   Yin, Xiaoxv ^a   Lu, Zuxun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; CHINA; DRUG MISUSE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HOSPITAL; HUMAN; META ANALYSIS; OUTPATIENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; STANDARD; SYSTEMATIC REVIEW; UPPER RESPIRATORY TRACT INFECTION; DRUG UTILIZATION; INAPPROPRIATE PRESCRIBING; RESPIRATORY TRACT INFECTIONS; STATISTICS AND NUMERICAL DATA;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CHINA; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; RESPIRATORY TRACT INFECTIONS;

EID: 84969922958     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003587     Document Type: Review

References (30)

1. WHO. Antimicrobial Resistance: A Global Threat2000:http://apps.who. int/medicinedocs/collect/medicinedocs/pdf/s2248e/s2248e.pdf. Accessed April 25, 2016.
2. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10:S122-S129.
3. Malhotra-Kumar S, Lammens C, Coenen S, et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: A randomised, double-blind, placebo-controlled study. Lancet. 2007;369:482-490.
4. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
5. Gwaltney JM. The common cold. Edited by Mandell GL B, Bennett JE, Dolin REBT Principles and Practice of Infectious Disease, eds. . 4th ed. New York: Churchill Livingstone; 1995: 561-566.
6. WHO. Using Indicators to Measure Country Pharmaceutical Situations. 2006:http://apps.who.int/medicinedocs/index/assoc/s14101e/s14101e.pdf. Accessed April 25, 2016.
7. WHO. The World Medicines Situation 2004.2004:http://apps.who. int/medicinedocs/pdf/s6160e/s6160e.pdf. Accessed April 25, 2016.
8. WHO. The World Medicines Situation 2011.2011:http://apps.who. int/medicinedocs/documents/s18064en/s18064en.pdf. Accessed April 25, 2016.
9. WHO. The World Drug Situation 1988.1988:http://apps.who.int/medicinedocs/documents/s16222e/s16222e.pdf. Accessed April 25, 2016.
10. WHO. Medicines Use in Primary Care in Developing and Transitional Countries.2009:http://www.who.int/entity/medicines/publications/primary-care-8April09.pdf. Accessed April 25, 2016.
11. Arroll B. Antibiotics for upper respiratory tract infections: an overview of Cochrane reviews. Respir Med. 2005;99:255-261.
12. Li Y. China's misuse of antibiotics should be curbed. BMJ. 2014;348:g1083.
13. Kunin CM. Use of antimicrobial drugs in developing countries. Int J Antimicrob Agents. 1995;5:107-113.
14. Yin X, Song F, Gong Y, et al. A systematic review of antibiotic utilization in China. J Antimicrob Chemother. 2013;68:2445-2452.
15. Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 2011;28:63-67.
16. Jiang Q, Yu BN, Ying G, et al. Outpatient prescription practices in rural township health centers in Sichuan Province, China. BMC Health Serv Res. 2012;12:324.
17. Li Y, Xu J, Wang F, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood). 2012;31:1075-1082.
18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
19. WHO. How to investigate Drug Use in Health Facilities: Selected Drug Use Indicators-EDM Research Series No. 007. 1993: http://apps.who. int/medicinedocs/pdf/s2289e/s2289e.pdf. Accessed April 25, 2016.
20. NSAID. How to Investigate Antimicrobial Drug Use in Hospitals Selected Indicators.2008:http://pdf.usaid.gov/pdf-docs/pnadn079.pdf. Accessed April 25, 2016.
21. Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91:8-15.
22. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
23. Adriaenssens N, Coenen S, Tonkin-Crine S, et al. European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf. 2011;20:764-772.
24. Stone S, Gonzales R, Maselli J, et al. Antibiotic prescribing for patients with colds, upper respiratory tract infections, and bronchitis: A national study of hospital-based emergency departments. Ann Emerg Med. 2000;36:320-327.
25. Kotwani A, Holloway K. Antibiotic prescribing practice for acute, uncomplicated respiratory tract infections in primary care settings in New Delhi, India. Trop Med Int Health. 2014;19: 761-768.
26. Sun X, Jackson S, Carmichael GA, et al. Prescribing behaviour of village doctors under China's New Cooperative Medical Scheme. Soc Sci Med. 2009;68:1775-1779.
27. Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ. 2011;30:933-949.
28. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy. 2009;90:32-36.
29. Chen Z. Ministry of Health of China. Report on the Management of Clinical Use of Antimicrobials in China.2012:https://www. government.nl/documents/reports/2012/11/16/report-on-themanagement-of-clinical-use-of-antimicrobials-in-china. Accessed April 25, 2016.
30. China Imposes Regulation to Fight Antibiotics Abuses. 2012. https://www.china.org.cn/china/2012-08/01/content-26086915.htm. Accessed April 25, 2016.